drugset / Trial / NCT00202280

Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication

NCT00202280 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Vitamin B12,B6 and Folic Acid are effective with antipsychotic medication in the treatment of First Episode Psychosis.The B-complex Vitamins' homocysteine lowering properties may have an effect on cognition and symptoms. We are examining changes in symptoms and cognition over a 3 month period.

Timeline

Start
2004-09
Primary completion
2006-09
Completion
2009-06

Outcome

Missed primary endpoint

paper B-vitamin supplementation had no significant effects on Positive and Negative Syndrome Scale total (p = .749) PMID 30771856 ↗

paper or composite neurocognition (p = .785). PMID 30771856 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject B6 Other / unclassified 50 mg —
Subject Vitamin B12 Other / unclassified 0.4 mg —
Subject folic acid Other / unclassified 5 mg —

Indications